Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024

Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024

Table of Contents
1 Multiple Sclerosis Drugs Market Overview
1.1 Multiple Sclerosis Drugs Product Overview
1.2 Multiple Sclerosis Drugs Market Segment by Type
1.2.1 Injectable Medications
1.2.2 Oral Medications
1.2.3 Others
1.3 Global Multiple Sclerosis Drugs Market Size by Type
1.3.1 Global Multiple Sclerosis Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Multiple Sclerosis Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Multiple Sclerosis Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Multiple Sclerosis Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Multiple Sclerosis Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Multiple Sclerosis Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Multiple Sclerosis Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Multiple Sclerosis Drugs Sales Breakdown by Type (2018-2023)
2 Global Multiple Sclerosis Drugs Market Competition by Company
2.1 Global Top Players by Multiple Sclerosis Drugs Sales (2018-2023)
2.2 Global Top Players by Multiple Sclerosis Drugs Revenue (2018-2023)
2.3 Global Top Players by Multiple Sclerosis Drugs Price (2018-2023)
2.4 Global Top Manufacturers Multiple Sclerosis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Multiple Sclerosis Drugs Market Competitive Situation and Trends
2.5.1 Multiple Sclerosis Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Multiple Sclerosis Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Multiple Sclerosis Drugs Market
2.8 Key Manufacturers Multiple Sclerosis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Multiple Sclerosis Drugs Status and Outlook by Region
3.1 Global Multiple Sclerosis Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Multiple Sclerosis Drugs Historic Market Size by Region
3.2.1 Global Multiple Sclerosis Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Multiple Sclerosis Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Multiple Sclerosis Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Multiple Sclerosis Drugs Forecasted Market Size by Region
3.3.1 Global Multiple Sclerosis Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Multiple Sclerosis Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Multiple Sclerosis Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Multiple Sclerosis Drugs by Application
4.1 Multiple Sclerosis Drugs Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Multiple Sclerosis Drugs Market Size by Application
4.2.1 Global Multiple Sclerosis Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Multiple Sclerosis Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Multiple Sclerosis Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Multiple Sclerosis Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Multiple Sclerosis Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Multiple Sclerosis Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Multiple Sclerosis Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Multiple Sclerosis Drugs Sales Breakdown by Application (2018-2023)
5 North America Multiple Sclerosis Drugs by Country
5.1 North America Multiple Sclerosis Drugs Historic Market Size by Country
5.1.1 North America Multiple Sclerosis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Multiple Sclerosis Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Multiple Sclerosis Drugs Sales in Value by Country (2018-2023)
5.2 North America Multiple Sclerosis Drugs Forecasted Market Size by Country
5.2.1 North America Multiple Sclerosis Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Multiple Sclerosis Drugs Sales in Value by Country (2024-2029)
6 Europe Multiple Sclerosis Drugs by Country
6.1 Europe Multiple Sclerosis Drugs Historic Market Size by Country
6.1.1 Europe Multiple Sclerosis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Multiple Sclerosis Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Multiple Sclerosis Drugs Sales in Value by Country (2018-2023)
6.2 Europe Multiple Sclerosis Drugs Forecasted Market Size by Country
6.2.1 Europe Multiple Sclerosis Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Multiple Sclerosis Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Multiple Sclerosis Drugs by Region
7.1 Asia-Pacific Multiple Sclerosis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Multiple Sclerosis Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Multiple Sclerosis Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Multiple Sclerosis Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Multiple Sclerosis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Multiple Sclerosis Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Multiple Sclerosis Drugs Sales in Value by Region (2024-2029)
8 Latin America Multiple Sclerosis Drugs by Country
8.1 Latin America Multiple Sclerosis Drugs Historic Market Size by Country
8.1.1 Latin America Multiple Sclerosis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Multiple Sclerosis Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Multiple Sclerosis Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Multiple Sclerosis Drugs Forecasted Market Size by Country
8.2.1 Latin America Multiple Sclerosis Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Multiple Sclerosis Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Multiple Sclerosis Drugs by Country
9.1 Middle East and Africa Multiple Sclerosis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Multiple Sclerosis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Multiple Sclerosis Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Multiple Sclerosis Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Multiple Sclerosis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Multiple Sclerosis Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Multiple Sclerosis Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biogen
10.1.1 Biogen Company Information
10.1.2 Biogen Introduction and Business Overview
10.1.3 Biogen Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Biogen Multiple Sclerosis Drugs Products Offered
10.1.5 Biogen Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Multiple Sclerosis Drugs Products Offered
10.2.5 Sanofi Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Multiple Sclerosis Drugs Products Offered
10.3.5 Novartis Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Multiple Sclerosis Drugs Products Offered
10.4.5 Teva Recent Development
10.5 Merck KGaA
10.5.1 Merck KGaA Company Information
10.5.2 Merck KGaA Introduction and Business Overview
10.5.3 Merck KGaA Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merck KGaA Multiple Sclerosis Drugs Products Offered
10.5.5 Merck KGaA Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Multiple Sclerosis Drugs Products Offered
10.6.5 Bayer Recent Development
10.7 ACORDA
10.7.1 ACORDA Company Information
10.7.2 ACORDA Introduction and Business Overview
10.7.3 ACORDA Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ACORDA Multiple Sclerosis Drugs Products Offered
10.7.5 ACORDA Recent Development
10.8 Mallinckrodt
10.8.1 Mallinckrodt Company Information
10.8.2 Mallinckrodt Introduction and Business Overview
10.8.3 Mallinckrodt Multiple Sclerosis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mallinckrodt Multiple Sclerosis Drugs Products Offered
10.8.5 Mallinckrodt Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Multiple Sclerosis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Multiple Sclerosis Drugs Industrial Chain Analysis
11.4 Multiple Sclerosis Drugs Market Dynamics
11.4.1 Multiple Sclerosis Drugs Industry Trends
11.4.2 Multiple Sclerosis Drugs Market Drivers
11.4.3 Multiple Sclerosis Drugs Market Challenges
11.4.4 Multiple Sclerosis Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Multiple Sclerosis Drugs Distributors
12.3 Multiple Sclerosis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Injectable Medications
Table 2. Major Company of Oral Medications
Table 3. Major Company of Others
Table 4. Global Multiple Sclerosis Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Multiple Sclerosis Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global Multiple Sclerosis Drugs Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Multiple Sclerosis Drugs Sales by Type (2018-2023) & (US& Million)
Table 8. Global Multiple Sclerosis Drugs Market Share in Value by Type (2018-2023)
Table 9. Global Multiple Sclerosis Drugs Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Multiple Sclerosis Drugs Sales by Type (2024-2029) & (K Units)
Table 11. Global Multiple Sclerosis Drugs Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Multiple Sclerosis Drugs Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Multiple Sclerosis Drugs Sales Market Share in Value by Type (2024-2029)
Table 14. Global Multiple Sclerosis Drugs Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Multiple Sclerosis Drugs Sales by Type (2018-2023) & (K Units)
Table 16. North America Multiple Sclerosis Drugs Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Multiple Sclerosis Drugs Sales (K Units) by Type (2018-2023)
Table 18. Europe Multiple Sclerosis Drugs Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Multiple Sclerosis Drugs Sales (K Units) by Type (2018-2023)
Table 20. Asia-Pacific Multiple Sclerosis Drugs Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Multiple Sclerosis Drugs Sales (K Units) by Type (2018-2023)
Table 22. Latin America Multiple Sclerosis Drugs Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Multiple Sclerosis Drugs Sales (K Units) by Type (2018-2023)
Table 24. Middle East and Africa Multiple Sclerosis Drugs Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Multiple Sclerosis Drugs Sales by Company (2018-2023) & (K Units)
Table 26. Global Multiple Sclerosis Drugs Sales Share by Company (2018-2023)
Table 27. Global Multiple Sclerosis Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Multiple Sclerosis Drugs Revenue Share by Company (2018-2023)
Table 29. Global Market Multiple Sclerosis Drugs Price by Company (2018-2023) & (USD/Unit)
Table 30. Global Multiple Sclerosis Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Multiple Sclerosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Multiple Sclerosis Drugs Market
Table 34. Key Manufacturers Multiple Sclerosis Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Multiple Sclerosis Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Multiple Sclerosis Drugs Sales by Region (2018-2023) & (K Units)
Table 38. Global Multiple Sclerosis Drugs Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Multiple Sclerosis Drugs Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Multiple Sclerosis Drugs Sales Market Share in Value by Region (2018-2023)
Table 41. Global Multiple Sclerosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 42. Global Multiple Sclerosis Drugs Sales by Region (2024-2029) & (K Units)
Table 43. Global Multiple Sclerosis Drugs Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Multiple Sclerosis Drugs Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Multiple Sclerosis Drugs Sales Market Share in Value by Region (2024-2029)
Table 46. Global Multiple Sclerosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Multiple Sclerosis Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Multiple Sclerosis Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Global Multiple Sclerosis Drugs Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Multiple Sclerosis Drugs Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Multiple Sclerosis Drugs Sales Market Share in Value by Application (2018-2023)
Table 52. Global Multiple Sclerosis Drugs Price by Application (2018-2023) & (USD/Unit)
Table 53. Global Multiple Sclerosis Drugs Sales by Application (2024-2029) & (K Units)
Table 54. Global Multiple Sclerosis Drugs Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Multiple Sclerosis Drugs Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Multiple Sclerosis Drugs Sales Market Share in Value by Application (2024-2029)
Table 57. Global Multiple Sclerosis Drugs Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Multiple Sclerosis Drugs Sales by Application (2018-2023) (K Units)
Table 59. North America Multiple Sclerosis Drugs Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Multiple Sclerosis Drugs Sales by Application (2018-2023) (K Units)
Table 61. Europe Multiple Sclerosis Drugs Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Multiple Sclerosis Drugs Sales by Application (2018-2023) (K Units)
Table 63. Asia-Pacific Multiple Sclerosis Drugs Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Multiple Sclerosis Drugs Sales by Application (2018-2023) (K Units)
Table 65. Latin America Multiple Sclerosis Drugs Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Multiple Sclerosis Drugs Sales by Application (2018-2023) (K Units)
Table 67. Middle East and Africa Multiple Sclerosis Drugs Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Multiple Sclerosis Drugs Sales by Country (2018-2023) & (K Units)
Table 69. North America Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Multiple Sclerosis Drugs Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Multiple Sclerosis Drugs Sales Market Share in Value by Country (2018-2023)
Table 72. North America Multiple Sclerosis Drugs Sales by Country (2024-2029) & (K Units)
Table 73. North America Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Multiple Sclerosis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Multiple Sclerosis Drugs Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Multiple Sclerosis Drugs Sales by Country (2018-2023) & (K Units)
Table 77. Europe Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Multiple Sclerosis Drugs Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Multiple Sclerosis Drugs Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Multiple Sclerosis Drugs Sales by Country (2024-2029) & (K Units)
Table 81. Europe Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Multiple Sclerosis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Multiple Sclerosis Drugs Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Multiple Sclerosis Drugs Sales by Region (2018-2023) & (K Units)
Table 85. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Multiple Sclerosis Drugs Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Multiple Sclerosis Drugs Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Multiple Sclerosis Drugs Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Multiple Sclerosis Drugs Sales by Country (2018-2023) & (K Units)
Table 93. Latin America Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Multiple Sclerosis Drugs Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Multiple Sclerosis Drugs Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Multiple Sclerosis Drugs Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Multiple Sclerosis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Multiple Sclerosis Drugs Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Multiple Sclerosis Drugs Sales by Country (2018-2023) & (K Units)
Table 101. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Multiple Sclerosis Drugs Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Multiple Sclerosis Drugs Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Multiple Sclerosis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Value by Country (2024-2029)
Table 108. Biogen Company Information
Table 109. Biogen Introduction and Business Overview
Table 110. Biogen Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Biogen Multiple Sclerosis Drugs Product
Table 112. Biogen Recent Development
Table 113. Sanofi Company Information
Table 114. Sanofi Introduction and Business Overview
Table 115. Sanofi Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Sanofi Multiple Sclerosis Drugs Product
Table 117. Sanofi Recent Development
Table 118. Novartis Company Information
Table 119. Novartis Introduction and Business Overview
Table 120. Novartis Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Novartis Multiple Sclerosis Drugs Product
Table 122. Novartis Recent Development
Table 123. Teva Company Information
Table 124. Teva Introduction and Business Overview
Table 125. Teva Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Teva Multiple Sclerosis Drugs Product
Table 127. Teva Recent Development
Table 128. Merck KGaA Company Information
Table 129. Merck KGaA Introduction and Business Overview
Table 130. Merck KGaA Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Merck KGaA Multiple Sclerosis Drugs Product
Table 132. Merck KGaA Recent Development
Table 133. Bayer Company Information
Table 134. Bayer Introduction and Business Overview
Table 135. Bayer Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Bayer Multiple Sclerosis Drugs Product
Table 137. Bayer Recent Development
Table 138. ACORDA Company Information
Table 139. ACORDA Introduction and Business Overview
Table 140. ACORDA Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. ACORDA Multiple Sclerosis Drugs Product
Table 142. ACORDA Recent Development
Table 143. Mallinckrodt Company Information
Table 144. Mallinckrodt Introduction and Business Overview
Table 145. Mallinckrodt Multiple Sclerosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Mallinckrodt Multiple Sclerosis Drugs Product
Table 147. Mallinckrodt Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Multiple Sclerosis Drugs Market Trends
Table 151. Multiple Sclerosis Drugs Market Drivers
Table 152. Multiple Sclerosis Drugs Market Challenges
Table 153. Multiple Sclerosis Drugs Market Restraints
Table 154. Multiple Sclerosis Drugs Distributors List
Table 155. Multiple Sclerosis Drugs Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Multiple Sclerosis Drugs Product Picture
Figure 2. Global Multiple Sclerosis Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Multiple Sclerosis Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Multiple Sclerosis Drugs Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Injectable Medications
Figure 6. Global Injectable Medications Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Oral Medications
Figure 8. Global Oral Medications Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Multiple Sclerosis Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Multiple Sclerosis Drugs Sales Market Share by Type in 2022 & 2029
Figure 13. North America Multiple Sclerosis Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Multiple Sclerosis Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Multiple Sclerosis Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Multiple Sclerosis Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Multiple Sclerosis Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Multiple Sclerosis Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Multiple Sclerosis Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Multiple Sclerosis Drugs Revenue in 2022
Figure 25. Multiple Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Adults
Figure 27. Global Adults Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Children
Figure 29. Global Children Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Multiple Sclerosis Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Multiple Sclerosis Drugs Sales Market Share by Application in 2022 & 2029
Figure 32. North America Multiple Sclerosis Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Multiple Sclerosis Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Multiple Sclerosis Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Multiple Sclerosis Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Multiple Sclerosis Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Multiple Sclerosis Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Multiple Sclerosis Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Multiple Sclerosis Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Multiple Sclerosis Drugs Manufacturing Cost Structure
Figure 43. Multiple Sclerosis Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fingolimod Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Multiple Sclerosis Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78

The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......

Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......

Fingolimod - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77

The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......

Global Fingolimod Market Research Report 2023, Forecast to 2028

Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133

Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......

Global Fingolimod Professional Survey Report 2023, Forecast to 2028

Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101

Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......

Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024

Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......

Global Multiple Sclerosis Drugs Market Research Report 2023

Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......

Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122

Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs